ES530669A0 - Un procedimiento para la preparacion de nuevos derivados de fosfolipidos - Google Patents

Un procedimiento para la preparacion de nuevos derivados de fosfolipidos

Info

Publication number
ES530669A0
ES530669A0 ES530669A ES530669A ES530669A0 ES 530669 A0 ES530669 A0 ES 530669A0 ES 530669 A ES530669 A ES 530669A ES 530669 A ES530669 A ES 530669A ES 530669 A0 ES530669 A0 ES 530669A0
Authority
ES
Spain
Prior art keywords
phosfolipids
procedure
preparation
new derivatives
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES530669A
Other languages
English (en)
Other versions
ES8602027A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Publication of ES530669A0 publication Critical patent/ES530669A0/es
Publication of ES8602027A1 publication Critical patent/ES8602027A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H9/00Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
    • C07H9/02Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
    • C07H9/04Cyclic acetals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/091Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/10Phosphatides, e.g. lecithin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/117Esters of phosphoric acids with cycloaliphatic alcohols
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H11/00Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
    • C07H11/04Phosphates; Phosphites; Polyphosphates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/08Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals directly attached to carbocyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES530669A 1982-07-30 1984-03-15 Un procedimiento para la preparacion de nuevos derivados de fosfolipidos Expired ES8602027A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8222020 1982-07-30

Publications (2)

Publication Number Publication Date
ES530669A0 true ES530669A0 (es) 1985-05-01
ES8602027A1 ES8602027A1 (es) 1985-05-01

Family

ID=10532013

Family Applications (3)

Application Number Title Priority Date Filing Date
ES524610A Granted ES524610A0 (es) 1982-07-30 1983-07-29 Un procedimiento para la preparacion de nuevos derivados de fosfolipidos.
ES530669A Expired ES8602027A1 (es) 1982-07-30 1984-03-15 Un procedimiento para la preparacion de nuevos derivados de fosfolipidos
ES530668A Expired ES8604243A1 (es) 1982-07-30 1984-03-15 Un procedimiento para la preparacion de nuevos derivados de fosfolipidos

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES524610A Granted ES524610A0 (es) 1982-07-30 1983-07-29 Un procedimiento para la preparacion de nuevos derivados de fosfolipidos.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES530668A Expired ES8604243A1 (es) 1982-07-30 1984-03-15 Un procedimiento para la preparacion de nuevos derivados de fosfolipidos

Country Status (6)

Country Link
US (1) US4585762A (es)
EP (1) EP0100499A3 (es)
JP (1) JPS5942394A (es)
KR (1) KR840005464A (es)
DK (1) DK347383A (es)
ES (3) ES524610A0 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3239817A1 (de) * 1982-07-06 1984-01-12 Max Planck Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Neue glycerinderivate zur synthese von phospholipiden
JPS6122096A (ja) * 1984-07-09 1986-01-30 Kao Corp 糖リン酸エステルおよびその製造方法
IT1244546B (it) * 1991-02-01 1994-07-15 Mediolanum Farmaceutici Spa Analoghi del fosfatidilinositolo inibitori della fosfolipasi c fosfatidilinositolo-specifica
JP2553171Y2 (ja) * 1991-05-31 1997-11-05 東陶機器株式会社 便器装置
SE9102068L (sv) * 1991-07-03 1993-01-04 Perstorp Ab Derivat av inositol, kompositioner innehaallande dessa samt anvaendning daerav
IT1255476B (it) * 1992-07-30 1995-11-02 Glicerofosfoderivati farmacologicamente attivi
DE4234130A1 (de) * 1992-10-09 1994-04-14 Max Planck Gesellschaft Phospholipase A¶2¶ inhibierende Phosphatidylcholinverbindungen
US5354853A (en) * 1993-03-12 1994-10-11 Genzyme Corporation Phospholipid-saccharide conjugates
US6551623B1 (en) 1993-09-09 2003-04-22 Lorus Therapeutics Inc. Immunomodulating compositions from bile
EP0717631B1 (en) 1993-09-09 2003-07-09 Lorus Therapeutics Inc. Immunomodulating compositions from bile
AU711294B2 (en) 1995-03-16 1999-10-07 Erin Mills Biotech Inc. Immunomodulating compositions from bile for the treatment of immune system disorders
US20040101569A1 (en) * 1996-05-16 2004-05-27 Lorus Therapeutics Inc. Immunomodulating compositions from bile
ATE308548T1 (de) * 2000-11-07 2005-11-15 I R B Istituto Di Ricerche Bio Glycerophosphoinositol-derivate als cytosolic a2 phospholipase modulatoren
WO2004022569A1 (en) * 2002-09-03 2004-03-18 Georgetown University Akt inhibitors, pharmaceutical compositions, and uses thereof
US20110218176A1 (en) * 2006-11-01 2011-09-08 Barbara Brooke Jennings-Spring Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2287901A1 (fr) * 1974-10-14 1976-05-14 Pasteur Institut Medicament immunostimulant contenant un derive d'ose ou de polyose phosphoryle
DE2659048A1 (de) * 1976-12-27 1978-07-06 Nattermann A & Cie Neue inositphosphatid-derivate und verfahren zur herstellung dieser verbindungen

Also Published As

Publication number Publication date
EP0100499A3 (en) 1985-06-12
JPS5942394A (ja) 1984-03-08
EP0100499A2 (en) 1984-02-15
ES8501410A1 (es) 1984-12-01
DK347383A (da) 1984-01-31
KR840005464A (ko) 1984-11-12
ES8602027A1 (es) 1985-05-01
ES530668A0 (es) 1985-07-01
ES8604243A1 (es) 1985-07-01
DK347383D0 (da) 1983-07-28
ES524610A0 (es) 1984-12-01
US4585762A (en) 1986-04-29

Similar Documents

Publication Publication Date Title
ES540812A0 (es) Un procedimiento para la preparacion de nuevos derivados delaminometil-oxooxazolidinil-benceno
ES524823A0 (es) Un procedimiento para la preparacion de nuevas fenetanolaminas
ES554935A0 (es) Un procedimiento para la preparacion de pirazolo- y piridazo-pirazolinas, -piridazinas y -diacepinas
ES502906A0 (es) Un procedimiento para la preparacion de nuevos derivados de imidazo-rifamicina
ES530714A0 (es) Un procedimiento para la preparacion de un derivado de carbostirilo
ES526295A0 (es) Un procedimiento para la preparacion de derivados de 1-normon-2-ilo
ES531659A0 (es) Un procedimiento para la preparacion de nuevos derivados de arilamida
ES521635A0 (es) Un procedimiento para la preparacion de nuevos derivados de fosfolipidos.
ES541229A0 (es) Un procedimiento para la preparacion de nuevos derivados delcromano
ES535980A0 (es) Un procedimiento para la preparacion de nuevos derivados de 2-oxo-imidazolina
ES524447A0 (es) Un procedimiento para la preparacion de nuevos derivados arilfenolicos.
ES524922A0 (es) Un procedimiento para la preparacion de nuevos derivados de 3-amino-pregn-5-eno
ES544140A0 (es) Un procedimiento para la preparacion de nuevos derivados de benzotiazina
ES524399A0 (es) Un procedimiento para la preparacion de derivados de milbenicina d
ES530668A0 (es) Un procedimiento para la preparacion de nuevos derivados de fosfolipidos
ES524317A0 (es) Un procedimiento para la preparacion de nuevos derivados de tienopirimidina.
ES492230A0 (es) Un procedimiento para la preparacion de nuevos derivados de carbostirilo
ES522389A0 (es) Un procedimiento para la preparacion de nuevos derivados de penem-2-tiosustituidos.
ES540347A0 (es) Un procedimiento para la preparacion de derivados de piperi-dina
ES527804A0 (es) Un procedimiento para la preparacion de derivados de oxacefalosporina
ES529879A0 (es) Un procedimiento para la preparacion de nuevos benzonitrilos
ES545776A0 (es) Un procedimiento para la preparacion de nuevos derivados de feniletanamina
ES527232A0 (es) Un procedimiento para la preparacion de nuevos derivados de triazol
ES526294A0 (es) Un procedimiento para la preparacion de derivados pentaciclicos
ES535101A0 (es) Un procedimiento para la preparacion de nuevos derivados de pirrol-2-acetilaminoacido